Literature DB >> 11994138

Interspecies conservation and differential expression of mouse desmoglein gene family.

My G Mahoney1, Anisha Simpson, Sirpa Aho, Jouni Uitto, Leena Pulkkinen.   

Abstract

Epithelial cell adhesion is mediated by intercellular junctions, called desmosomes. Desmogleins (Dsg; Dsg1, Dsg2 and Dsg3) are calcium-dependent transmembrane adhesion components of the desmosomes. While Dsg1 and Dsg3 are mainly restricted to stratified squamous epithelia, Dsg2 is expressed in essentially all desmosome-containing epithelia. In the epidermis, Dsg2 and Dsg3 are expressed in the basal keratinocytes while Dsg1 is expressed throughout the upper differentiating cell layers. To date, in mouse, only Dsg3 has been characterized by molecular cloning. In this study, we have cloned and characterized the mouse Dsg1 and Dsg2 genes. The full-length mouse Dsg1 cDNA (5.5 kb) contains an open reading frame (ORF) of 3171 bp encoding a precursor protein of 1057 amino acids. The Dsg2 cDNA (6.3 kb) has an ORF of 3366 bp coding for a precursor protein of 1122 amino acids. Mouse Dsg2 protein shares 76% identity with human DSG2 but only 26% and 33% identity with mouse Dsg1 and Dsg3, respectively. Analysis of intron/exon organization of the desmoglein genes revealed significant conservation. However, the mRNA expression patterns of these desmogleins during mouse embryonic development and in various adult tissues are variable. While Dsg2 and Dsg3 are expressed in all developmental stages, Dsg1 expression is delayed until day 15 of mouse embryos. In adult mouse tissues, Dsg2 is widely expressed while the expression of Dsg1 and Dsg3 is restricted to select tissues. In summary, while desmogleins share high homology at both the gene and protein level, their expression is spatially and temporally regulated, potentially contributing to their significant role in cell-cell adhesion during development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994138     DOI: 10.1034/j.1600-0625.2002.110203.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  7 in total

1.  Human Desmoglein-2 and Human CD46 Mediate Human Adenovirus Type 55 Infection, but Human Desmoglein-2 Plays the Major Roles.

Authors:  Ying Feng; Changhua Yi; Xinglong Liu; Linbing Qu; Wan Su; Tao Shu; Xuehua Zheng; Xianmiao Ye; Jia Luo; Mingli Hao; Xikui Sun; Liang Li; Xiaolin Liu; Chenchen Yang; Suhua Guan; Ling Chen; Liqiang Feng
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

2.  Increased expression of Dsg2 in malignant skin carcinomas: A tissue-microarray based study.

Authors:  Donna Brennan; Mÿ G Mahoney
Journal:  Cell Adh Migr       Date:  2009-04-04       Impact factor: 3.405

3.  Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14.

Authors:  Hongjie Wang; Zong-Yi Li; Ying Liu; Jonas Persson; Ines Beyer; Thomas Möller; Dilara Koyuncu; Max R Drescher; Robert Strauss; Xiao-Bing Zhang; James K Wahl; Nicole Urban; Charles Drescher; Akseli Hemminki; Pascal Fender; André Lieber
Journal:  Nat Med       Date:  2010-12-12       Impact factor: 53.440

4.  A role for caveolin-1 in desmoglein binding and desmosome dynamics.

Authors:  D Brennan; S Peltonen; A Dowling; W Medhat; K J Green; J K Wahl; F Del Galdo; M G Mahoney
Journal:  Oncogene       Date:  2011-08-15       Impact factor: 9.867

5.  Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer.

Authors:  Vishnu C Ramani; Leah Hennings; Randy S Haun
Journal:  BMC Cancer       Date:  2008-12-17       Impact factor: 4.430

6.  Streptococcal Cysteine Protease-Mediated Cleavage of Desmogleins Is Involved in the Pathogenesis of Cutaneous Infection.

Authors:  Tomoko Sumitomo; Yasushi Mori; Yuumi Nakamura; Mariko Honda-Ogawa; Seitaro Nakagawa; Masaya Yamaguchi; Hiroyuki Matsue; Yutaka Terao; Masanobu Nakata; Shigetada Kawabata
Journal:  Front Cell Infect Microbiol       Date:  2018-01-24       Impact factor: 5.293

Review 7.  Staphylococcus aureus Host Tropism and Its Implications for Murine Infection Models.

Authors:  Daniel M Mrochen; Liliane M Fernandes de Oliveira; Dina Raafat; Silva Holtfreter
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.